Table 2. Diagnoses of HIV-infected patients stratified by outcome.
Clinical condition | Deceased | Discharged | OR (95% CI) | P-value |
(n = 57) | (n = 236) | |||
Presumptive tuberculosis | 26 (46) | 67 (28) | 2.1 (1.1–3.9) | 0.02 |
Presumptive Pneumocystis jiroveci pneumonia | 15 (26) | 8 (3) | 10.2 (3.8–28.2) | <0.001 |
Presumptive histoplasmosis | 12 (21) | 9 (4) | 6.7 (2.5–18.6) | <0.001 |
Presumptive oesophasial candidiasis | 15 (26) | 12 (5) | 6.7 (2.7–16.5) | <0.001 |
Malignancy * | 5 (9) | 6 (3) | 3.7 (0.9–14.3) | 0.04 |
Presumptive Cytomegalovirus infection | 4 (7) | 11 (5) | 1.5 (0.4–5.5) | 0.5 |
Presumptive Cerebral Toxoplasmosis | 2 (4) | 1 (1) | 8.6 (0.5–242.6) | 0.09 |
Presumptive Cryptococcal meningitis | 1 (2) | 5 (2) | — | 0.48 |
Herpes viral infection (H. simplex & H. zoster) | 0 | 8 (3) | — | 0.36 |
Bacteremia | 21 (37) | 22 (9) | 5.7 (2.7–12.0) | <0.001 |
Isolation of multiple organisms in blood | 5 (9) | 1 (1) | 22.6 (2.5–522.1) | <0.001 |
Bacteriuria | 21 (38) | 43 (18) | 2.7 (1.4–5.3) | 0.003 |
*Non-Hodgkin's lymphoma (4 cases), central nervous system tumors (2 cases), and Kaposi's sarcoma (1 case), mediastinal sarcoma (1 case), cervical cancer (1 case), carcinoma of the tongue (1 case) and adenocarcinoma of the colon (1 case).
Figures represent n (%), unless specified. OR: odds ratio. CI: confidence interval. IQR: interquartile range.